Our structures of CCK1R and CCK2R will set the stage for future efforts to develop novel therapeutic strategies to selectively target CCK2R to fight anxiety, depression, pain, and possibly other emotional diseases without causing side effects in the intestinal tract. Here, CCKBR is linked to depressive disorder.